U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07273409) titled 'Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not' on Sept. 24.
Brief Summary: Pancreatic neuroendocrine tumours (pan-NETs) are neoplasms arising from the endocrine cells of the pancreas. Although pan-NET are quite rare, the incidence is on the rise and together with other abdominal neuroendocrine tumours an approximate incidence in Sweden would be 850 patients per year extrapolating from Norwegian data. Pan-NET are divided into symptomatic hormone producing tumours (such as insulinomas/glucagonomas/VIPomas) or non-functioning tumours that often are asymptomatic. As early symptoms often are lacking in non-function...